Abstract
This phase I/II study was conducted to determine the maximum recommended dose of pemetrexed when given in combination with a fixed dose of cisplatin, and the efficacy, toxicity and association of 5,10-methylenetetrahydrofolate reductase (MTHFR) variants with this pemetrexed--cisplatin combination, in patients with unresectable, advanced gastric carcinoma. Patients 18-70 years of age, with stage IV disease or post-surgery recurrence, no earlier palliative chemotherapy, 0 or 1 Eastern Cooperative Oncology Group performance status, were included. The cisplatin dose was 75 mg/m. In phase I, the initial dose of pemetrexed was 600 mg/m, escalated in 100 mg/m increments. In phase II, efficacy, including overall response rate, overall survival, as well as toxicity and MTHFR pharmacogenetics were investigated. Phase I enrolled 16 patients; 700 mg/m was defined as pemetrexed recommended dose. Thirteen serious adverse events were reported; the most common grade 3/4 toxicities were haematologic (10 of 13, 76.9%). Phase II enrolled 73 patients, 69 qualified for safety and 68 for efficacy analysis; 65 for pharmacogenomic analysis. Overall response rate was 23.5% (14.1%, 35.4%), disease control rate 55.9%, median overall survival 11.8 months ...Continue Reading
References
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A WilsM Buyse
Aug 1, 1994·British Journal of Cancer·A SulkesJ Verweij
Jun 15, 1993·Cancer·N K KimH J Kim
Aug 28, 1998·Molecular Genetics and Metabolism·I WeisbergR Rozen
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J Bagley, J Selhub
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N BokuI Hyodo
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R S Go, A A Adjei
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ThödtmannA R Hanauske
Jul 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U VanhoeferJ A Wils
Jun 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S R AlbertsC J H van de Velde
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Sep 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaW John
May 1, 2004·Clinical Lung Cancer·Nasser H Hanna
Nov 3, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S WöhrerM Hejna
Dec 21, 2004·Pharmacogenetics·Marie-Christine EtienneGérard Milano
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Jun 17, 2005·Cancer Science·Jee Hyun KimYung-Jue Bang
Feb 21, 2006·World Journal of Gastroenterology : WJG·Ryan Swan, Thomas J Miner
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annamaria RuzzoMauro Magnani
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna D WagnerWolfgang E Fleig
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xifeng WuJaffer A Ajani
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemUNKNOWN V325 Study Group
Dec 26, 2006·Pharmacogenomics·Sachie InoueMayumi Mochizuki
Oct 26, 2007·Cancer Chemotherapy and Pharmacology·Yeul Hong KimYung-Jue Bang
Dec 22, 2007·Cell Biochemistry and Function·Renfang MaoSongbin Fu
Dec 29, 2007·American Journal of Epidemiology·Stefania BocciaEmanuela Taioli
Jan 4, 2008·The New England Journal of Medicine·David CunninghamUNKNOWN Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom
Mar 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Salah-Eddin Al-BatranUNKNOWN Arbeitsgemeinschaft Internistische Onkologie
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Jul 31, 2008·British Journal of Cancer·J-L LeeY J Min
Sep 25, 2008·Cancer Chemotherapy and Pharmacology·Jae Jin LeeJin-Hyuk Choi
Jan 16, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena De Mattia, Giuseppe Toffoli
Feb 12, 2009·The Journal of Rheumatology·Mark C Fisher, Bruce N Cronstein
Feb 17, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CelioE Bajetta
Citations
Sep 4, 2012·Journal of Medical Case Reports·Takashi SatoYoshiaki Ishigatsubo
Feb 5, 2014·BMC Cancer·Susanne BlankKatja Ott
Apr 16, 2014·The Pharmacogenomics Journal·A CorriganA M Marinaki
Dec 5, 2014·British Journal of Cancer·D S ZhangR H Xu
Jun 9, 2016·Pharmacogenomics·Zoulikha M Zaïr, Donald Rj Singer
Nov 6, 2012·The Journal of Urology·Bertram E YuhSumanta K Pal
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xin-En HuangJin Xiang
Jun 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Guo-Li WeiJin-Hai Tang
Mar 17, 2019·Cancer Chemotherapy and Pharmacology·Duo LiuMei Dong
Apr 20, 2013·Oncology Letters·Wen-Juan LiQiu-Yun Zhang
Sep 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Hai LanYan Li